Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Nutrition and metabolism in musculoskeletal disorders. | Front Nutr | 2023 | 37680894 | PubTator, text mining | PubMed |
| The role of lactoferrin in bone remodeling: evaluation of its potential in targeted delivery and treatment of metabolic bone diseases and orthopedic conditions. | Front Endocrinol (Lausanne) | 2023 | 37680888 | PubTator, text mining | PubMed |
| Comparative analysis of anchorage strength and histomorphometric changes after implantation of miniscrews in adults and adolescents: an experimental study in Beagles. | BMC Oral Health | 2023 | 37670309 | PubTator, text mining | PubMed |
| High-normal free thyroxine level is related with decreased bone mineral density in nonobese male patients with type 2 diabetes over 50 years old. | Ther Adv Chronic Dis | 2023 | 37664176 | PubTator, text mining | PubMed |
| Radiographic and Clinical Evaluation of Implant Prosthetic Treatment with One Piece versus Two Piece Dental Implants: A Comparative Prospective Study. | J Pharm Bioallied Sci | 2023 | 37654392 | PubTator, text mining | PubMed |
| Mechanism of miRNA-31 Regulating Wnt/β-catenin Signaling Pathway by Targeting Satb2 in the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells. | J Musculoskelet Neuronal Interact | 2023 | 37654220 | PubTator, text mining | PubMed |
| Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism. | Endocrine | 2023 | 37651007 | PubTator, text mining | PubMed |
| Research progress on the role of lncRNA-miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis. | Front Endocrinol (Lausanne) | 2023 | 37645421 | PubTator, text mining | PubMed |
| Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws in Bone Metastatic Breast and Prostate Cancer under Zoledronate Treatment: A Retrospective Analysis from 10 Years of Evaluation. | Asian Pac J Cancer Prev | 2023 | 37642054 | PubTator, text mining | PubMed |
| Knockdown of Bach1 protects periodontal bone regeneration from inflammatory damage. | J Cell Mol Med | 2023 | 37602966 | PubTator, text mining | PubMed |
| Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation. | JCI Insight | 2023 | 37581932 | PubTator, text mining | PubMed |
| Sustained release of a highly specific GSK3β inhibitor SB216763 in the PCL scaffold creates an osteogenic niche for osteogenesis, anti-adipogenesis, and potential angiogenesis. | Front Bioeng Biotechnol | 2023 | 37576993 | PubTator, text mining | PubMed |
| The association between serum adipokines levels with senile osteoporosis: a systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2023 | 37576959 | PubTator, text mining | PubMed |
Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection - A post-treatment re-initiation bone biopsy-based case study. | Bone Rep | 2023 | 37576928 | PubTator, text mining | PubMed |
| Osteoimmune Properties of Mesoporous Bioactive Nanospheres: A Study on T Helper Lymphocytes. | Nanomaterials (Basel) | 2023 | 37570501 | PubTator, text mining | PubMed |
| Engineering a Pro-Osteogenic Secretome through the Transient Silencing of the Gene Encoding Secreted Frizzled Related Protein 1. | Int J Mol Sci | 2023 | 37569774 | PubTator, text mining | PubMed |
| A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL. | Int J Mol Sci | 2023 | 37569526 | PubTator, text mining | PubMed |
| Editorial: Potential effects and mechanisms of bone homeostasis on tumor bone metastasis. | Front Endocrinol (Lausanne) | 2023 | 37564977 | PubTator, text mining | PubMed |
| Nacre-mimetic cerium-doped nano-hydroxyapatite/chitosan layered composite scaffolds regulate bone regeneration via OPG/RANKL signaling pathway. | J Nanobiotechnology | 2023 | 37550715 | PubTator, text mining | PubMed |
All-on-Four Case Rehabilitated with Fully Digitally Fabricated Prosthesis Milled from Graphene-Reinforced Poly Methyl Methacrylate Puck Using Indigenously Developed Intraoral and Extraoral Scanning Methods. | Contemp Clin Dent | 2023 | 37547432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=28